Actual product packaging and materials may contain more and/or different information than that shown on our website
BoscoAInmanDMSteeleMRWuGSotoIMarsh-ArmstrongNet al
Primary Cellular Pathways GLP-1 Receptor Activation GLP1 Component GLP1 activates glucagon-like peptide-1 receptors expressed throughout the central nervous system and peripheral tissues, producing multiple metabolic effects: Insulin secretion enhancement in pancreatic beta cells in a glucose-dependent manner Glucagon suppression reducing hepatic glucose output and glycogenolysis Gastric emptying delay slowing nutrient absorption and prolonging satiety signals Central appetite suppression through hypothalamic GLP-1 receptor activation Beta cell preservation with potential enhancement of pancreatic beta cell function Research demonstrates that GLP1s 94% structural homology to native GLP-1, combined with modifications at positions 8, 26, and 34, provides resistance to dipeptidyl peptidase-4 degradation while maintaining full receptor activation

Whilst amino acids may have a role as adjunctive support for some individuals with mild ED, they should not replace proper medical assessment and evidence-based treatment
It is available for laboratory research under research-use-only terms
Immediate Absorption: Intramuscular or subcutaneous administration delivers quick correction of B12 deficiency and maximum bioavailability